Apollon Wealth Management LLC Has $3.66 Million Stock Holdings in CME Group Inc. $CME

Apollon Wealth Management LLC grew its stake in CME Group Inc. (NASDAQ:CME) by 7.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,295 shares of the financial services provider’s stock after buying an additional 949 shares during the period. Apollon Wealth Management LLC’s holdings in CME Group were worth $3,664,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. GQG Partners LLC boosted its position in shares of CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after purchasing an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after purchasing an additional 2,089,935 shares in the last quarter. Nuveen LLC bought a new stake in shares of CME Group during the 1st quarter valued at about $218,842,000. Alliancebernstein L.P. boosted its position in shares of CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after purchasing an additional 808,740 shares in the last quarter. Finally, Egerton Capital UK LLP boosted its position in shares of CME Group by 79.4% during the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock valued at $459,003,000 after purchasing an additional 765,773 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 1.0%

Shares of NASDAQ:CME opened at $271.45 on Friday. The business’s 50 day simple moving average is $268.89 and its two-hundred day simple moving average is $271.22. The firm has a market cap of $97.83 billion, a P/E ratio of 26.28, a PEG ratio of 5.72 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the company earned $2.56 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research report on Wednesday. JPMorgan Chase & Co. upped their target price on CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research report on Thursday, September 25th. Oppenheimer upped their target price on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and increased their price target for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Finally, Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $281.00.

Insider Buying and Selling

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares in the company, valued at $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock worth $3,527,956 over the last three months. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.